Sort by Year:
Sort by Division:
04/07/14
Par Pharmaceutical Begins Shipment of Potassium Chloride Extended-Release Capsules
04/01/14
Par Pharmaceutical Names Terrance J. Coughlin Chief Operating Officer
03/13/14
Par Pharmaceutical Announces Fourth Quarter and Full Year 2013 Conference Call
02/20/14
Par Pharmaceutical Names Antonio R. Pera Chief Commercial Officer
01/21/14
Par Pharmaceutical to Acquire JHP Pharmaceuticals
01/16/14
Par Pharmaceutical Begins Shipment of Generic Lanoxin®
11/20/13
Par Pharmaceutical Begins Shipment of Generic Focalin XR® Capsules
10/24/13
Par Pharmaceutical’s Karen O’Connor Receives 2013 Cardinal Health Supply Chain Excellence Award
10/07/13
Par Pharmaceutical Begins Shipment of Generic Kapvay®
09/25/13
Par Pharmaceutical Begins Shipment of Generic Glucotrol XL®
09/23/13
Par Pharmaceutical Begins Shipment of KHEDEZLA (desvenlafaxine)
08/20/13
Par Pharmaceutical Receives Approval of sANDA for Bupropion Hydrochloride Extended-Release Tablets USP (XL), 300 mg
08/05/13
Par Pharmaceutical Announces Quarterly Conference Call
07/31/13
Par Pharmaceutical’s Martin Wilson Named to New Jersey Law Journal’s
07/18/13
Par Pharmaceutical Begins Shipment of Generic Trilipix®
05/22/13
Par Pharmaceutical Begins Shipment of Generic Atacand®
05/08/13
Par Pharmaceutical Announces Quarterly Conference Call
04/01/13
NJBIZ Honors New Jersey’s General Counsels
03/14/13
Par Pharmaceutical Begins Shipment of Generic Luvox CR®
03/11/13
Par Pharmaceutical Announces Quarterly Conference Call
01/18/13
Par Pharmaceutical Begins Shipment of Generic Lamictal® XR
01/02/13
Par Pharmaceutical Begins Shipment of Rizatriptan Benzoate Tablets
12/05/12
Par Pharmaceutical Begins Shipment of Generic Atacand HCT®
11/28/12
Par Pharmaceutical Begins Shipment of Generic Symbyax®
 First | Previous | Next | Last